DE2543214A1 - Nucleasebestaendiger hydrophiler komplex aus polyriboinosin-polyribocytidylsaeure und einem polylysin sowie verfahren zu seiner herstellung - Google Patents

Nucleasebestaendiger hydrophiler komplex aus polyriboinosin-polyribocytidylsaeure und einem polylysin sowie verfahren zu seiner herstellung

Info

Publication number
DE2543214A1
DE2543214A1 DE19752543214 DE2543214A DE2543214A1 DE 2543214 A1 DE2543214 A1 DE 2543214A1 DE 19752543214 DE19752543214 DE 19752543214 DE 2543214 A DE2543214 A DE 2543214A DE 2543214 A1 DE2543214 A1 DE 2543214A1
Authority
DE
Germany
Prior art keywords
poly
complex
lysine
carboxymethyl cellulose
polyriboinosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19752543214
Other languages
German (de)
English (en)
Inventor
Hilton B Levy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States Department of Health and Human Services
Original Assignee
United States Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United States Department of Health and Human Services filed Critical United States Department of Health and Human Services
Publication of DE2543214A1 publication Critical patent/DE2543214A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
DE19752543214 1974-09-27 1975-09-27 Nucleasebestaendiger hydrophiler komplex aus polyriboinosin-polyribocytidylsaeure und einem polylysin sowie verfahren zu seiner herstellung Withdrawn DE2543214A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/509,966 US3952097A (en) 1974-09-27 1974-09-27 Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid

Publications (1)

Publication Number Publication Date
DE2543214A1 true DE2543214A1 (de) 1976-05-20

Family

ID=24028821

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752543214 Withdrawn DE2543214A1 (de) 1974-09-27 1975-09-27 Nucleasebestaendiger hydrophiler komplex aus polyriboinosin-polyribocytidylsaeure und einem polylysin sowie verfahren zu seiner herstellung

Country Status (13)

Country Link
US (1) US3952097A (enExample)
JP (1) JPS5186484A (enExample)
BE (1) BE833838A (enExample)
CA (2) CA1038375A (enExample)
CH (1) CH616432A5 (enExample)
DE (1) DE2543214A1 (enExample)
FR (1) FR2285893A1 (enExample)
GB (1) GB1488209A (enExample)
HU (1) HU174918B (enExample)
IL (1) IL48099A (enExample)
NL (1) NL7511370A (enExample)
SE (1) SE403783B (enExample)
ZA (1) ZA755865B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024241A (en) * 1974-09-27 1977-05-17 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
US4388306A (en) * 1980-06-04 1983-06-14 Merck & Co., Inc. Pharmaceutical composition comprising modified polyriboinosinic-polyribocytidylic acid, for induction of interferon in primates
US4389395A (en) * 1981-01-09 1983-06-21 Lerner A Martin Low molecular weight complex of polyriboinosinic-polyribocytidylic acid and method of inducing interferon
US7229822B1 (en) * 2000-02-29 2007-06-12 Univ Columbia Melanoma differentation associated gene-5 and vectors and cells containing same
KR101203401B1 (ko) * 2005-06-08 2012-11-22 이쉥 바이오파마(싱가포르)피티이 리미티드 폴리이노신산-폴리시티딜산-기초 보조제
US20070166239A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
US20070166800A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
CN101687900A (zh) * 2007-03-07 2010-03-31 恩文塔生物制药公司 双链锁核酸组合物
JP5775451B2 (ja) 2008-06-19 2015-09-09 バリエーション バイオテクノロジーズ インコーポレイティド インフルエンザを処置するための組成物および方法
US20110097418A1 (en) * 2009-05-29 2011-04-28 Variation Biotechnologies, Inc. Compositions and methods for treating influenza
MX2012000372A (es) 2009-07-06 2012-02-28 Variation Biotechnologies Inc Metodos para preparar vesiculas y formulaciones producidas a partir de las mismas.
US9907746B2 (en) 2009-07-06 2018-03-06 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
CA2840079C (en) 2010-07-06 2018-07-03 Variation Biotechnologies Inc. Compositions and methods for treating influenza
US10736844B2 (en) 2011-01-13 2020-08-11 Variation Biotechnologies Inc. Compositions and methods for treating viral infections
AU2012205315B2 (en) 2011-01-13 2017-05-04 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
CA2894442C (en) 2012-01-12 2020-01-21 Variation Biotechnologies Inc. Compositions and methods for treating viral infections
EP4008354A1 (en) 2012-01-27 2022-06-08 Variation Biotechnologies Inc. Methods and compositions for therapeutic agents
WO2016105274A1 (en) 2014-12-23 2016-06-30 Yisheng Biopharma (Singapore) Pte Ltd A rabies composition comprising pika adjuvant

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2851453A (en) * 1954-08-09 1958-09-09 Smith Kline French Lab Cellulose derivative product, compositions comprising the same and their preparation
US3066075A (en) * 1960-07-25 1962-11-27 G W Carnrick Co Compositions comprising amphetamine and carboxymethyl cellulose in chemically combined form
US3493559A (en) * 1967-05-29 1970-02-03 Upjohn Co 2-thiocytosine ribofuranosides
BE757291A (fr) * 1969-10-10 1971-04-09 Smith Kline French Lab Complexe antiviral de arn et d'un polysaccharide
GB1364987A (en) * 1971-06-19 1974-08-29 Merck Patent Gmbh Biologically active two component complexes
BE790953A (fr) * 1971-11-05 1973-05-03 Beecham Group Ltd Matiere biologiquement active
US3853846A (en) * 1973-02-12 1974-12-10 Abbott Lab INOSINE-5 -Carboxylates

Also Published As

Publication number Publication date
HU174918B (hu) 1980-04-28
NL7511370A (nl) 1976-03-30
FR2285893A1 (fr) 1976-04-23
CA1038375A (en) 1978-09-12
IL48099A0 (en) 1975-11-25
CA1091648B (en) 1980-12-16
FR2285893B1 (enExample) 1980-08-08
US3952097A (en) 1976-04-20
JPS5186484A (en) 1976-07-29
GB1488209A (en) 1977-10-12
IL48099A (en) 1978-04-30
CH616432A5 (enExample) 1980-03-31
ZA755865B (en) 1976-08-25
SE403783B (sv) 1978-09-04
SE7510812L (sv) 1976-03-29
BE833838A (fr) 1976-01-16

Similar Documents

Publication Publication Date Title
DE3045078A1 (de) Nucleasebestaendiger hydrophiler komplex aus polyriboinosinsaeure, verfahren zu seiner herstellung und verwendung desselben
DE4134854C2 (enExample)
CH640140A5 (de) Verfahren zur herstellung von intravenoes injizierbarem gamma-globulin.
DE69827357T2 (de) Menschliches Wachstumshormon enthaltende pharmazeutische Zusammensetzung
DE60034898T2 (de) Antiallergische Zusammensetzung, die OLIGOSACCHARIDe und eine Saponine oder eine basische Aminosäure enthält, zur topischen Verabreichung oder Inhalation
CH616432A5 (enExample)
DE2404416A1 (de) Neurotropisch wirksames mittel und verfahren zu seiner herstellung
DE69004451T2 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
EP0679395A1 (de) Pharmazeutische Zubereitungen aud der Basis einer Ketoprofenlösung in weichen Gelatinekapseln und Verfahren zu deren Herstellung
DE3119510C2 (enExample)
DE2137011A1 (de) Aus Konjac-Mehl gewonnenes Konjac-Mannan sowie dessen Herstellung und Verwendung
DE2505814C2 (de) Verfahren zur Herstellung feinverteilter Mikropartikel von Tyrosin mit einem Gehalt eines darin dispergierten, mit Glutaraldehyd modifizierten Allergens und diese Mikropartikel als Wirkstoff enthaltende injizierbare Lösung
AT408719B (de) Mittel zur behandlung von hepatitis c
DE2036935B2 (de) Diisonicotinsaeurehydrazid-methansulfonat des d(+)2,2'-(aethylendiimino)-di-l- butanols, verfahren zur herstellung desselben und diese verbindung enthaltende arzneimittel
DE2064296A1 (de) Verfahren zur Herstellung eines Inhi bitors pathologischer Prozesse und Ver wendung desselben
DE2147094A1 (de) Virostatisch wirksames arzneimittel
AT330953B (de) Verfahren zur herstellung eines pharmazeutischen praparates zur verbesserung der zellatmung
DE1667890A1 (de) Kosmetische und pharmazeutische Mittel zur Behandlung der Haut
DE1467743A1 (de) Verfahren zur Herstellung eines Praeparats mit verlaengerter Vitamin B 12-Wirkung
DE890261C (de) Verfahren zur Herstellung von Reizstoffen
DE2015804A1 (de) Verfahren zur Herstellung eines antigenen oder allergenen Extraktes
DE2036113B2 (de) Wäßriges Tetramisolpräparat
DE3626306A1 (de) Verwendung von 15-deoxyspergualin als arzneimittel
DE934664C (de) Verfahren zur Herstellung von Proteohormonverbindungen
AT215073B (de) Verfahren zur Herstellung von Corticotropinpräparaten mit verlängerter Wirksamkeit

Legal Events

Date Code Title Description
8162 Independent application
8139 Disposal/non-payment of the annual fee